metformin has been researched along with Double Aortic Arch in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study was purported to assess the effect of metformin and empagliflozin on MAO expression, oxidative stress and vascular reactivity in internal mammary arteries harvested from overweight patients with coronary heart disease subjected to bypass grafting." | 4.31 | Metformin and empagliflozin modulate monoamine oxidase-related oxidative stress and improve vascular function in human mammary arteries. ( Borza, C; Buriman, DG; Crețu, OM; Deaconu, L; Feier, HB; Ionică, LN; Lascu, A; Merce, AP; Muntean, DM; Sturza, A, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lascu, A | 1 |
| Ionică, LN | 1 |
| Buriman, DG | 1 |
| Merce, AP | 1 |
| Deaconu, L | 1 |
| Borza, C | 1 |
| Crețu, OM | 1 |
| Sturza, A | 1 |
| Muntean, DM | 1 |
| Feier, HB | 1 |
1 other study available for metformin and Double Aortic Arch
| Article | Year |
|---|---|
Metformin and empagliflozin modulate monoamine oxidase-related oxidative stress and improve vascular function in human mammary arteries.
Topics: Humans; Mammary Arteries; Metformin; Monoamine Oxidase; Overweight; Oxidative Stress; Reactive Oxyge | 2023 |